Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sofia D. Merajver
Observed names:
Sofia E. Merajver,
Sofia Merajver
Institutions:
University of Michigan,
Michigan Medicine
Observed institutions:
University of Michigan,
Michigan Medicine
OpenAlex ID:
A5132883436
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
2026
·
Eleonora Nicolò
, François Bertucci
, et al.
·
Cancer
·
4
Abstract B089: Targeting metabolic vulnerabilities in cancer through structure-guided discovery of novel malic enzyme inhibitors
2026
·
Ben Krinkel
, Yuliana Yosaatmadja
, et al.
·
Clinical Cancer Research
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma
2026
·
Carl Koschmann
, Kallen Schwark
, et al.
·
Research Square
PDF
Abstract 1757: Synergy of BCL-2 and MEK/HDAC inhibition in IBC and non-IBC models: Potential for a first IBC specific therapy
2026
·
Hassan Zbib
, Habib Serhan
, et al.
·
Cancer Research
Abstract 6501: Preclinical evidence for synergistic activity of alectinib and everolimus in ALK-positive non-small cell lung cancer
2026
·
Hamadi Madhi
, Habib Serhan
, et al.
·
Cancer Research
Abstract 1766: Dual EGFR and Bcl-2 inhibition overcomes resistance in sinonasal squamous cell carcinoma
2026
·
Rhea Raghavan
, Athena Apfel
, et al.
·
Cancer Research
Abstract 469: Quaratusugene ozeplasmid mediated TUSC2 upregulation in EML4-ALK bearing non-small cell lung carcinoma induces apoptosis and is highly effective in preclinical studies.
2026
·
Ananya Banerjee
, Neeke Busette
, et al.
·
Cancer Research
Abstract 1062: Longitudinal monitoring of circulating tumor cells (CTC) reveals dynamic CTC behaviors associated with disease progression and survival in ALK-positive NSCLC
2026
·
Yuru Chen
, Shamileh Fouladdel
, et al.
·
Cancer Research
Abstract 2412: Malic enzyme inhibition as a strategy to exploit metabolic reprogramming in cancer: A structure-based approach
2026
·
Ben Andrew Krinkel
, Yuliana Yosaatmadja
, et al.
·
Cancer Research
Abstract B032: STING agonist-loaded nanoparticles in ALK-driven lung cancer inhibit tumor growth through local and systemic immune microenvironment remodeling
2026
·
Marisa E. Aikins
, Abdullah Saeed
, et al.
·
Cancer Research
PATH-02. Molecular characterization of brain tumors from stereotactic needle biopsy surgical waste
2025
·
Jack Wadden
, Tiffany Adam
, et al.
·
Neuro-Oncology Pediatrics
Show more works
View as search
Works count:
11
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type